233 related articles for article (PubMed ID: 27405497)
21. Utilization of non-steroidal anti-inflammatory drugs in Quebec: adherence to the Canadian consensus on prescription guidelines.
Moride Y; Ducruet T; Boivin JF; Lavoie F; Rochon S
Can J Clin Pharmacol; 2005; 12(2):e201-11. PubMed ID: 15998959
[TBL] [Abstract][Full Text] [Related]
22. Alzheimer's disease, inflammation and non-steroidal anti-inflammatory drugs.
Ferencik M; Novak M; Rovensky J; Rybar I
Bratisl Lek Listy; 2001; 102(3):123-32. PubMed ID: 11433600
[TBL] [Abstract][Full Text] [Related]
23. Pro-apoptotic effect of nonsteroidal anti-inflammatory drugs on synovial fibroblasts.
Kusunoki N; Yamazaki R; Kawai S
Mod Rheumatol; 2008; 18(6):542-51. PubMed ID: 18642053
[TBL] [Abstract][Full Text] [Related]
24. An introduction to aspirin, NSAIDs, and COX-2 inhibitors for the primary prevention of cardiovascular events and cancer and their potential preventive role in bladder carcinogenesis: part I.
Moyad MA
Semin Urol Oncol; 2001 Nov; 19(4):294-305. PubMed ID: 11769881
[TBL] [Abstract][Full Text] [Related]
25. Structural basis for selective inhibition of cyclooxygenase-2 by anti-inflammatory agents.
Kurumbail RG; Stevens AM; Gierse JK; McDonald JJ; Stegeman RA; Pak JY; Gildehaus D; Miyashiro JM; Penning TD; Seibert K; Isakson PC; Stallings WC
Nature; 1996 Dec 19-26; 384(6610):644-8. PubMed ID: 8967954
[TBL] [Abstract][Full Text] [Related]
26. Persistency of use of COX-2-specific inhibitors and non-specific non-steroidal anti-inflammatory drugs (NSAIDs) in Quebec.
Moride Y; Ducruet T; Rochon S; Lavoie F
Rheumatology (Oxford); 2003 Nov; 42 Suppl 3():iii17-22. PubMed ID: 14585914
[TBL] [Abstract][Full Text] [Related]
27. Investigational drugs targeting the prostaglandin E2 signaling pathway for the treatment of inflammatory pain.
Grösch S; Niederberger E; Geisslinger G
Expert Opin Investig Drugs; 2017 Jan; 26(1):51-61. PubMed ID: 27841017
[TBL] [Abstract][Full Text] [Related]
28. [Selective inhibition of cyclooxygense (COX-2)].
Gömör B
Orv Hetil; 1999 Feb; 140(8):395-9. PubMed ID: 10083811
[TBL] [Abstract][Full Text] [Related]
29. Non-steroidal anti-inflammatory drugs, cyclooxygenase-2 and the bone healing process.
Vuolteenaho K; Moilanen T; Moilanen E
Basic Clin Pharmacol Toxicol; 2008 Jan; 102(1):10-4. PubMed ID: 17973900
[TBL] [Abstract][Full Text] [Related]
30. Changing perceptions and practices regarding aspirin, nonsteroidal anti-inflammatory drugs, and cyclooxygenase-2 selective nonsteroidal anti-inflammatory drugs among US primary care providers.
Elnachef N; Scheiman JM; Fendrick AM; Howden CW; Chey WD
Aliment Pharmacol Ther; 2008 Nov; 28(10):1249-58. PubMed ID: 18729848
[TBL] [Abstract][Full Text] [Related]
31. Kinetic modelling of NSAID action on COX-1: focus on in vitro/in vivo aspects and drug combinations.
Goltsov A; Maryashkin A; Swat M; Kosinsky Y; Humphery-Smith I; Demin O; Goryanin I; Lebedeva G
Eur J Pharm Sci; 2009 Jan; 36(1):122-36. PubMed ID: 19028575
[TBL] [Abstract][Full Text] [Related]
32. [Application of non-steroidal anti-inflammatory drugs to enhance 5-fluorouracil efficacy in experimental systems].
Réti A
Magy Onkol; 2010 Dec; 54(4):377-81. PubMed ID: 21163769
[TBL] [Abstract][Full Text] [Related]
33. High on treatment platelet reactivity against aspirin by non-steroidal anti-inflammatory drugs--pharmacological mechanisms and clinical relevance.
Hohlfeld T; Saxena A; Schrör K
Thromb Haemost; 2013 May; 109(5):825-33. PubMed ID: 23238666
[TBL] [Abstract][Full Text] [Related]
34. Celecoxib, NSAIDs and the skeleton.
O'Connor JP; Lysz T
Drugs Today (Barc); 2008 Sep; 44(9):693-709. PubMed ID: 19137124
[TBL] [Abstract][Full Text] [Related]
35. Clinical pharmacology of selective COX-2 inhibitors.
Capone ML; Tacconelli S; Sciulli MG; Patrignani P
Int J Immunopathol Pharmacol; 2003; 16(2 Suppl):49-58. PubMed ID: 14552704
[TBL] [Abstract][Full Text] [Related]
36. Update on clinical developments with celecoxib, a new specific COX-2 inhibitor: what can we expect?
Geis GS
Scand J Rheumatol Suppl; 1999; 109():31-7. PubMed ID: 10422544
[TBL] [Abstract][Full Text] [Related]
37. Cyclooxygenase Inhibition Safety and Efficacy in Inflammation-Based Psychiatric Disorders.
Perrone MG; Centonze A; Miciaccia M; Ferorelli S; Scilimati A
Molecules; 2020 Nov; 25(22):. PubMed ID: 33217958
[TBL] [Abstract][Full Text] [Related]
38. The Importance of the Structural Similarity of Drugs Used for Depression and Inflammation, Two Comorbid Diseases.
Bayram FEÖ; Reis R; Tunçer B; Sipahi H
Curr Top Med Chem; 2018; 18(16):1416-1421. PubMed ID: 30129414
[TBL] [Abstract][Full Text] [Related]
39. Non-steroidal anti-inflammatory drugs and melanoma.
Sanz-Motilva V; Martorell-Calatayud A; Nagore E
Curr Pharm Des; 2012; 18(26):3966-78. PubMed ID: 22632752
[TBL] [Abstract][Full Text] [Related]
40. Current Therapeutic Approaches for Targeting Inflammation in Depression and Cardiovascular Disease.
Zuzarte P; Duong A; Figueira ML; Costa-Vitali A; Scola G
Curr Drug Metab; 2018; 19(8):674-687. PubMed ID: 29512447
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]